This is a new treatment in the early stages now being testing on individuals diagnosed with various autoimmune disorders including MS. It is an experimental immunotherapy designed to deeply "reset" the immune system by genetically reprogramming a patient's T cells to hunt down and destroy disease-driving B cell.
Category:
Medications
Stage:
Proposed Idea
Priority:
Normal
Good fit for:
Other Researchers